Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
If medical marijuana evokes a picture of folks sitting in circles passing marijuana cigarettes, then you'll likely be surprised to learn how drugmakers like GW Pharmaceuticals (NASDAQ: GWPH ) are using the plant to develop next-generation medicine.
GW Pharma has been studying ways to use the chemical compounds found in marijuana since 1998, and the company already markets one marijuana based drug, Sativex, in more 11 countries. That drug combines two key marijuana cannabinoids, THC and CBD, to treat multiple sclerosis.
However, GW Pharma doesn't believe the medical benefit from THC and CBD is limited to MS. It thinks they could play an important role in improving patient treatment for a variety of disease, including diabetes.
http://www.fool.com/investing/general/2014/04/27/can-marijuana-treat-diabetes.aspx
Like, cosmic, man... 😉
GW Pharma has been studying ways to use the chemical compounds found in marijuana since 1998, and the company already markets one marijuana based drug, Sativex, in more 11 countries. That drug combines two key marijuana cannabinoids, THC and CBD, to treat multiple sclerosis.
However, GW Pharma doesn't believe the medical benefit from THC and CBD is limited to MS. It thinks they could play an important role in improving patient treatment for a variety of disease, including diabetes.
http://www.fool.com/investing/general/2014/04/27/can-marijuana-treat-diabetes.aspx
Like, cosmic, man... 😉
